Accessibility Menu
Cuprina (Cayman) logo

Cuprina (Cayman)(NASDAQ) CUPR

Market Cap$7.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-91%
5 YearN/A
1 Year-60%
1 Month-0%
$2.85
-2.07%
-0.06Today
Cuprina (Cayman) last closing stock price
MetricPriceDate
Last closeUSD 2.912026-08-31
Cuprina (Cayman) stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.6%USD 2.732026-08-24
1 month-0.34%USD 2.922026-07-31
3 month+8.59%USD 2.682026-06-02
Year to date-9.08%USD 3.202025-12-31
1 year-60.46%USD 7.362025-08-29
Since inception-91.23%USD 33.202025-04-10

Cuprina (Cayman) Financials at a Glance

Market Cap

$7.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-$1.34

P/E Ratio

-2.18

Dividend

$0.00

Beta (Volatility)

3.97 (High)

Price

$2.85

Volume

2,503.825

Open

$2.90

Previous Close

$2.91

Daily Range

$2.81 - $2.91

52-Week Range

$1.76 - $19.60

Estimated Earnings Date

Jul 27, 2026

CUPR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cuprina (Cayman)

Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise focused on innovative solutions for managing persistent wounds. The company specializes in its MEDIFLY brand, which offers medical-grade sterile blowfly larvae bio-dressing products for chronic wound care. Additionally, Cuprina extends its reach into the health and beauty market with a variety of cosmeceutical items.

Products and Services
  • MEDIFLY brand bio-dressing products for chronic wounds
  • Cosmeceutical items targeting health and beauty markets
  • Research and development in advanced wound management solutions
Growth Outlook
  • Expansion into new markets anticipated to drive revenue growth
  • Increased focus on R&D to enhance product offerings
  • Strategic partnerships expected to bolster market presence
Financial Highlights
  • Recent quarterly revenue of 26,790 SGD, indicating market traction
  • Cash and cash equivalents of 3,117,682 SGD, providing liquidity
  • Current ratio of 2.35, reflecting strong short-term financial health
Cuprina Holdings is positioned in the healthcare sector, specifically within medical instruments and supplies. The company's innovative approach to wound management through its MEDIFLY products addresses a significant need in the healthcare market. The recent quarterly revenue demonstrates the potential for growth, while the strong liquidity position indicates the ability to navigate operational challenges. The current ratio suggests that Cuprina is well-equipped to meet its short-term obligations, which is crucial for sustaining operations and pursuing growth initiatives. Overall, Cuprina Holdings presents an intriguing opportunity for investors interested in the biotechnology and healthcare sectors.
AI Generated • Aug 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10

CEO

Yong Qi Quek

Website

www.cuprina.com

Headquarters

Singapore, CE 169201, SG

CUPR Financials

Key Financial Metrics (TTM)

Gross Margin

-1.29%

Operating Margin

-9154.62%

Net Income Margin

-9366.75%

Return on Equity

-1569.05%

Return on Capital

-82.48%

Return on Assets

-54.95%

Earnings Yield

-45.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.68M

Volume

2.50K

Avg. Volume

2.99M

Financials (TTM)

Gross Profit

-SGD 16.50K

Operating Income

-SGD 2.83M

EBITDA

-SGD 2.81M

Operating Cash Flow

-SGD 3.73M

Capital Expenditure

-SGD 53.56K

Free Cash Flow

-SGD 3.78M

Cash & ST Invst.

SGD 3.12M

Total Debt

SGD 482.72K

Cuprina (Cayman) Performance Analysis

Cuprina (Cayman) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SGD 41,044-5.7%
20232023-12-31SGD 75,02782.8%
20242024-12-31SGD 36,157-51.8%
20252025-12-31SGD 38,1865.6%
Cuprina (Cayman) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30N/A
Q42024-12-31N/A
Q22025-06-30N/A
Q42025-12-31N/A
Cuprina (Cayman) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SGD -0.29105.3%
20232023-12-31SGD -0.316.5%
20242024-12-31SGD -0.4440.1%
20252025-12-31SGD -1.33206.3%
Cuprina (Cayman) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30N/A
Q42024-12-31N/A
Q22025-06-30N/A
Q42025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

SGD 26.79K

N/A

Gross Profit

-SGD 16.50K

N/A

Gross Margin

-61.59%

N/A

Market Cap

$7.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$780.27K

N/A

Employees

10

N/A

Net Income

-SGD 2.69M

N/A

EBITDA

-SGD 2.81M

N/A

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

SGD 3.12M

+8741.2%

Total Debt

SGD 482.72K

+296.3%

Accounts Receivable

SGD 255.95K

+20.8%

Inventory

SGD 0.00

-100.0%

Long Term Debt

SGD 333.76K

+480.3%

Short Term Debt

SGD 148.96K

+131.6%

Return on Assets

-54.95%

N/A

Return on Invested Capital

-84.76%

N/A

Free Cash Flow

-SGD 3.78M

N/A

Operating Cash Flow

-SGD 3.73M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CURXCuranex Pharmaceuticals Inc Common Stock
$4.30+0.67%
PCSAProcessa Pharmaceuticals, Inc.
$2.05+0.49%
PULMPulmatrix, Inc.
$1.53+3.74%
CRISCuris, Inc.
$1.42-4.70%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$219.72-0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.36-0.06%
INTCIntel
$88.83-0.01%
BIAFbioAffinity Technologies
$6.37+0.40%

Questions About CUPR

What is the current price of Cuprina (Cayman)?

Cuprina (Cayman) is trading at $2.85 per share.

What is the 52-week range for Cuprina (Cayman)?

Over the past 52 weeks, Cuprina (Cayman) has traded between $1.76 and $19.60.

How much debt does Cuprina (Cayman) have?

As of the most recent reporting period, Cuprina (Cayman) reported total debt of SGD 375.36K.

How much cash does Cuprina (Cayman) have on hand?

Cuprina (Cayman) reported SGD 2.42M in cash and cash equivalents in its most recent financial results.

What is Cuprina (Cayman)’s dividend yield?

Cuprina (Cayman) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services